Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Clinical trial NCT00052845 · COMPLETED
Trial details
- NCT number
- NCT00052845
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2006-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.